| Literature DB >> 31128888 |
J Antonio Gomez1, Ulrika Beitnere1, David J Segal2.
Abstract
Epigenome editing refers to the generation of precise chromatin alterations and their effects on gene expression and cell biology. Until recently, much of the efforts in epigenome editing were limited to tissue culture models of disease. However, the convergence of techniques from different fields including mammalian genetics, virology, and CRISPR engineering is advancing epigenome editing into a new era. Researchers are increasingly embracing the use of multicellular model organisms to test the role of specific chromatin alterations in development and disease. The challenge of successful live-animal epigenomic editing will depend on a well-informed foundation of the current methodologies for cell-specific delivery and editing accuracy. Here we review the opportunities for basic research and therapeutic applications.Entities:
Keywords: CRISPR; animal models; cancer; delivery; epigenomic editing; neurodevelopment
Mesh:
Year: 2019 PMID: 31128888 PMCID: PMC6608710 DOI: 10.1016/j.tig.2019.04.007
Source DB: PubMed Journal: Trends Genet ISSN: 0168-9525 Impact factor: 11.639